文献速递神经康复言语与吞咽障碍疼痛康复

重复经颅磁刺激治疗卒中后功能障碍:系统综述概述

Repetitive transcranial magnetic stimulation for management of post-stroke impairments: An overview of systematic reviews.
PubMed 文献 · J Rehabil Med · 2020-02-07

结果显示rTMS对吞咽障碍和偏侧忽略有中等质量证据支持,对运动功能(上肢功能、日常生活活动)有低至中等质量证据支持,对失语和卒中后抑郁有低质量证据支持。结论认为缺乏高质量证据支持rTMS常规用于卒中幸存者。

要点

  • rTMS对吞咽障碍和偏侧忽略有中等质量证据支持。
  • rTMS对运动功能(上肢功能、日常生活活动)有低至中等质量证据支持。
  • rTMS对失语和卒中后抑郁仅有低质量证据支持。

核心结论

  • 尽管rTMS广泛使用,但缺乏高质量证据支持其常规用于卒中幸存者的治疗。
  • 需要进一步研究确定不同rTMS方案的差异作用和长期效果。

研究设计与样本

  • 检索Cochrane Library、MEDLINE、CINAHL、EMBASE和PubMed截至2019年1月15日的系统综述。
  • 使用AMSTAR工具评估方法学质量,使用GRADE工具评估证据质量。

主要发现

  • rTMS对吞咽障碍和偏侧忽略有中等质量证据支持的有益效果。
  • rTMS对运动功能(上肢功能、日常生活活动)有低至中等质量证据支持的有益效果。
  • rTMS对失语和卒中后抑郁有低质量证据支持的有益效果。
  • 所选综述中应用的rTMS方案和测量的结局多样。

关键数值与推荐

  • 吞咽障碍和偏侧忽略:中等质量证据支持rTMS有益。
  • 运动功能(上肢功能、日常生活活动):低至中等质量证据支持rTMS有益。
  • 失语和卒中后抑郁:低质量证据支持rTMS有益。

临床怎么用

  • rTMS可考虑用于卒中后吞咽障碍和偏侧忽略的康复,证据质量中等。
  • rTMS用于卒中后运动功能康复的证据质量为低至中等。
  • rTMS用于卒中后失语和抑郁的证据质量低,应谨慎使用。

局限性

  • 缺乏高质量证据支持rTMS常规用于卒中幸存者。
  • 不同综述中rTMS方案和结局测量多样,难以统一结论。
  • 需要进一步研究确定不同方案的差异作用和长期效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate evidence from published systematic reviews of clinical trials to determine the effectiveness of repetitive transcranial magnetic stimulation (rTMS) in stroke population. METHODS: The Cochrane Library, MEDLINE, CINAHL, EMBASE, and PubMed were searched for systematic reviews up to 15 January 2019. Three authors independently screened the reviews and assessed the methodological quality, using Assessment of Multiple Systematic Reviews (AMSTAR) appraisal tool. Quality of evidence for outcomes evaluated within the reviews was appraised with Grade of Recommendation, Assessment, Development and Evaluation (GRADE) tool. RESULTS: Twelve reviews (n = 9,117 participants) evaluated the effectiveness of rTMS on motor and non-motor (aphasia, depression, dysphagia and cognition) functions. The rTMS protocols applied and outcomes measured were diverse amongst the selected reviews. The findings suggest beneficial effect of rTMS with: "moderate quality" evidence for dysphagia and hemineglect, "low to moderate quality" evidence for motor function (upper limb function, daily activities), and "low quality" evidence for aphasia and post-stroke depression. CONCLUSION: Despite widespread use of rTMS, high-quality evidence for its routine use for the treatment of stroke survivors is lacking. Further studies are required to establish differential roles of various protocols and long-term effects of rTMS in the stroke population.

来源:J Rehabil Med,查看原文。版权归原作者所有。

引用

  1. Kim WJ, Rosselin C, Amatya B, et al. Repetitive transcranial magnetic stimulation for management of post-stroke impairments: An overview of systematic reviews. J Rehabil Med. 2020. PMID: 31922207. doi:10.2340/16501977-2637

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。